Andrew C Peet
Overview
Explore the profile of Andrew C Peet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
2023
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Carlin D, Babourina-Brooks B, Davies N, Wilson M, Peet A
J Magn Reson Imaging
. 2018 Apr;
49(1):195-203.
PMID: 29697883
Background: Metabolite concentrations are fundamental biomarkers of disease and prognosis. Magnetic resonance spectroscopy (MRS) is a noninvasive method for measuring metabolite concentrations; however, quantitation is affected by T relaxation. Purpose:...
22.
Manias K, Gill S, Zarinabad N, Davies P, English M, Ford D, et al.
Neurooncol Pract
. 2018 Apr;
5(1):18-27.
PMID: 29692921
Background: Magnetic resonance spectroscopy (MRS) aids noninvasive diagnosis of pediatric brain tumors, but use in clinical practice is not well documented. We aimed to review clinical use of MRS, establish...
23.
Kohe S, Bennett C, Gill S, Wilson M, McConville C, Peet A
Oncotarget
. 2018 Mar;
9(13):11336-11351.
PMID: 29541417
The rare pediatric embryonal tumors retinoblastoma, medulloblastoma and neuroblastoma derive from neuroectodermal tissue and share similar histopathological features despite different anatomical locations and diverse clinical outcomes. As metabolism can reflect...
24.
Orphanidou-Vlachou E, Kohe S, Brundler M, MacPherson L, Sun Y, Davies N, et al.
Pathobiology
. 2018 Feb;
85(3):157-168.
PMID: 29428932
Aims: Metabolite levels can be measured non-invasively using in vivo 1H magnetic resonance spectroscopy (MRS). These tumour metabolite profiles are highly characteristic for tumour type in childhood brain tumours; however,...
25.
Webb E, Elliott L, Carlin D, Wilson M, Hall K, Netherton J, et al.
J Clin Endocrinol Metab
. 2017 Nov;
103(4):1330-1341.
PMID: 29165577
Context: Brain white matter hyperintensities are seen on routine clinical imaging in 46% of adults with congenital adrenal hyperplasia (CAH). The extent and functional relevance of these abnormalities have not...
26.
Meeus E, Zarinabad N, Manias K, Novak J, Rose H, Dehghani H, et al.
J Magn Reson Imaging
. 2017 Nov;
47(6):1475-1486.
PMID: 29159937
Background: Pediatric retroperitoneal tumors in the renal bed are often large and heterogeneous, and their diagnosis based on conventional imaging alone is not possible. More advanced imaging methods, such as...
27.
Meeus E, Novak J, Dehghani H, Peet A
MAGMA
. 2017 Oct;
31(2):269-283.
PMID: 29075909
Objective: This study aimed to investigate the reliability of intravoxel incoherent motion (IVIM) model derived parameters D and f and their dependence on b value distributions with a rapid three...
28.
Fetit A, Novak J, Rodriguez D, Auer D, Clark C, Grundy R, et al.
NMR Biomed
. 2017 Oct;
31(1).
PMID: 29073725
Brain tumours are the most common solid cancers in children in the UK and are the most common cause of cancer deaths in this age group. Despite current advances in...
29.
Manias K, Gill S, MacPherson L, Foster K, Oates A, Peet A
Eur J Cancer
. 2016 Dec;
72:251-265.
PMID: 28011138
Imaging is central to management of solid tumours in children. Conventional magnetic resonance imaging (MRI) is the standard imaging modality for tumours of the central nervous system (CNS) and limbs...
30.
OConnor J, Aboagye E, Adams J, Aerts H, Barrington S, Beer A, et al.
Nat Rev Clin Oncol
. 2016 Oct;
14(3):169-186.
PMID: 27725679
Imaging biomarkers (IBs) are integral to the routine management of patients with cancer. IBs used daily in oncology include clinical TNM stage, objective response and left ventricular ejection fraction. Other...